ZymoGenetics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released

companiesandmarkets.com

2009-11-12 19:37:04 - ZymoGenetics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/zymogenetics ..

Zymogenetics, Inc.is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases. The Company´s therapeutic focus is in the areas of hemostasis, inflammatory and autoimmune diseases, cancer and viral infections. Its first internally developed product candidate, RECOTHROM Thrombin ((also referred to as rThrombin), topical (Recombinant), was approved by the United States Food and

 

 

Drug Administration (FDA) on January 17, 2008, for use as a topical hemostat to control moderate bleeding during surgical procedures and is being marketed in the United States. More from Reuters »

ZymoGenetics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

ZymoGenetics, Inc. (ZymoGenetics) is a biotechnology company which is principally engaged in the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human disease. The company’s current programs focus on the hemostasis, inflammatory and autoimmune diseases, cancer and viral infections. ZymoGenetics entered into various research collaborations to develop new therapeutics products. It has many products under clinical development and its first internally developed product candidate RECOTHROM Thrombin received FDA approval in 2008. The company is headquartered in Washington, the United States.

The ZymoGenetics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.